Genetic Cancer Risk Assessment and Counseling: Recommendations of the National Society of Genetic Counselors

These cancer genetic counseling recommendations describe the medical, psychosocial, and ethical ramifications of identifying at-risk individuals through cancer risk assessment with or without genetic testing. They were developed by members of the Practice Issues Subcommittee of the National Society of Genetic Counselors Cancer Genetic Counseling Special Interest Group. The information contained in this document is derived from extensivereview of the current literature on cancer genetic risk assessment and counseling as well as the personal expertise of genetic counselors specializing in cancer genetics. The recommendations are intended to provid information about the process of genetic counseling and risk assessment for hereditary cancer disorders rather than specific information about individual syndromes. Key components include the intake (medical and family histories), psychosocial assessment (assessment of risk perception), cancer risk assessment (determination and communication of risk), molecular testing for hereditary cancer syndromes (regulations, informed consent, and counseling process), and follow-up considerations. These recommendations should not be construed as dictating an exclusive course of management, nor does use of such recommendations guarantee a particular outcome. These recommendations do not displace a health care provider's professional judgment based on the clinical circumstances of a client.

[1]  Richard Berg,et al.  Sensitivity and specificity. , 2005, Clinical medicine & research.

[2]  A. Patenaude,et al.  Testing for cancer genes: Decisions, decisions , 1995, Nature Network Boston.

[3]  Peters Ja,et al.  ROLE OF THE GENETIC COUNSELOR IN FAMILIAL CANCER , 1996 .

[4]  J. E. Nash,et al.  Psychological responses to BRCA1 mutation testing: preliminary findings. , 1997, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[5]  J Benichou,et al.  Graphs to estimate an individualized risk of breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R. Love,et al.  The accuracy of patient reports of a family history of cancer. , 1985, Journal of chronic diseases.

[7]  P. Harper,et al.  Promoting safe and effective genetic testing in the United States: Final Report of the Task Force on Genetic Testing. , 1998, Community genetics.

[8]  C. Eng.  Will the real Cowden syndrome please stand up: revised diagnostic criteria , 2000, Journal of medical genetics.

[9]  L. Aaltonen,et al.  Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. , 1998, The New England journal of medicine.

[10]  Bartha Maria Knop.  ASHG statement. Professional disclosure of familial genetic information. The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure. , 1998, American journal of human genetics.

[11]  R. Laxová,et al.  Testing for cancer susceptibility genes in children. , 1999, Advances in pediatrics.

[12]  D J Schaid,et al.  Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. , 1999, The New England journal of medicine.

[13]  Kevin T. FitzGerald,et al.  An explication of the National Society of Genetic Counselors (NSGC) code of ethics , 1992, Journal of Genetic Counseling.

[14]  J L Mitchell,et al.  Cross-cultural issues in the disclosure of cancer. , 1998, Cancer practice.

[15]  C. Eng.  To be or not to BMP , 2001, Nature Genetics.

[16]  W. Rubinstein,et al.  Proportion of Heritable Paraganglioma Cases and Associated Clinical Characteristics , 2001, The Laryngoscope.

[17]  P. Goodfellow,et al.  Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC , 1997, Oncogene.

[18]  A. Patenaude,et al.  Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  B. Wilfond,et al.  Genetic Testing for Susceptibility to Adult-Onset Cancer: The Process and Content of Informed Consent , 1997 .

[20]  R. Croyle,et al.  Emotional and behavioral responses to genetic testing for susceptibility to cancer. , 1996, Oncology.

[21]  M. Greene,et al.  Genetics of breast cancer. , 1997, Mayo Clinic proceedings.

[22]  Holtzman Na,et al.  Promoting safe and effective genetic testing in the United States. Final report of the Task Force on Genetic Testing. , 1999, Journal of child and family nursing.

[23]  L. Fleisher,et al.  Health Insurance Portability and Accountability Act is here: What price privacy? , 2001, Genetics in Medicine.

[24]  W. Simpson,et al.  Results of a screening program for c‐cell disease (medullary thyroid cancer and c‐cell hyperplasia) , 1990, Cancer.

[25]  D. Carter.  Clinical Cancer Genetics: Risk Counseling and Management. , 1999 .

[26]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.

[27]  E. Thomson,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .

[28]  C. Rogers,et al.  Client-Centered Therapy , 1951 .

[29]  K. Schneider.  Counseling about Cancer: Strategies for Genetic Counseling , 2001 .

[30]  A. Zwinderman,et al.  Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. , 1998, The New England journal of medicine.

[31]  F. Couch,et al.  BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. , 1997, The New England journal of medicine.

[32]  Julie O. Culver,et al.  Genetic counseling for women with an intermediate family history of breast cancer. , 2000, American journal of medical genetics.

[33]  H. Grönberg,et al.  Age specific risks of familial prostate carcinoma , 1999, Cancer.

[34]  Siavash Ghaffari,et al.  A candidate prostate cancer susceptibility gene at chromosome 17p , 2001, Nature Genetics.

[35]  D. Berry,et al.  Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. , 1998, American journal of human genetics.

[36]  N. Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994 .

[37]  K Offit,et al.  BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. , 1997, JAMA.

[38]  Mhs,et al.  Management of Patients at High Risk for Breast Cancer , 2002 .

[39]  T. Sellers,et al.  Examination of the effect of nongenetic risk factors on the familial risk of breast cancer among relatives of postmenopausal breast cancer patients. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[40]  B. Trock,et al.  BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. , 1996, JAMA.

[41]  The genetics of hereditary melanoma and nevi , 1999, Cancer.

[42]  D. Evans,et al.  The accuracy of diagnoses as reported in families with cancer: a retrospective study , 1999, Journal of medical genetics.

[43]  Patricia D. Murphy,et al.  Genetic counseling in a navajo hereditary nonpolyposis colorectal cancer kindred , 1996, Cancer.

[44]  J. Benkendorf,et al.  Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. , 1997, Journal of the National Cancer Institute.

[45]  B. Yashar,et al.  A guide to genetic counseling , 1998 .

[46]  R. Croyle,et al.  Risk communication in genetic testing for cancer susceptibility. , 1999, Journal of the National Cancer Institute. Monographs.

[47]  E. Thomson,et al.  Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer: I. Hereditary Nonpolyposis Colon Cancer , 1997 .

[48]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[49]  R. Houlston,et al.  Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. , 1990, BMJ.

[50]  A. Baum,et al.  Stress and genetic testing for disease risk. , 1997, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[51]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[52]  R. Hanson,et al.  Psychological Responses In , 1978 .

[53]  M. Schwartz,et al.  The influence of psychological distress on use of genetic testing for cancer risk. , 1997, Journal of consulting and clinical psychology.

[54]  R. Bennett.  The Practical Guide to the Genetic Family History , 1999 .

[55]  D. Macdonald,et al.  Hereditary cancers in children and ethical and psychosocial implications. , 2000, Journal of pediatric nursing.

[56]  B. Peshkin,et al.  Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: The contributions of personality and appraisal , 1997, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[57]  Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  K. Calzone,et al.  Genetic Testing for Cancer Predisposition , 2002, Cancer nursing.

[59]  M. Skolnick,et al.  Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries , 1996 .

[60]  S. Richard,et al.  [Does hemangioblastoma exist outside von Hippel-Lindau disease?]. , 1994, Neuro-Chirurgie.

[61]  R. Bennett,et al.  Recommendations for standardized human pedigree nomenclature. Pedigree Standardization Task Force of the National Society of Genetic Counselors. , 1995, American journal of human genetics.

[62]  P. Hartge,et al.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.

[63]  K Offit,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. , 1997, JAMA.

[64]  D. Euhus.  Understanding Mathematical Models for Breast Cancer Risk Assessment and Counseling , 2001, The breast journal.

[65]  J. E. Nash,et al.  A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. , 1996, Journal of the National Cancer Institute.

[66]  N Risch,et al.  Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.

[67]  M. Witty.  Client-centered therapy. , 2006, The Harvard mental health letter.

[68]  Suzanne M. Miller,et al.  A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style. , 1996, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[69]  J. Stopfer,et al.  Role of the genetic counselor in familial cancer. , 1996, Oncology.

[70]  Kenneth Offit,et al.  Decision-Making About Genetic Testing Among Women at Familial Risk for Breast Cancer , 1997, Psychosomatic medicine.

[71]  B. Biesecker,et al.  Psychological issues in cancer genetics. , 1997, Seminars in oncology nursing.

[72]  S. Cummings,et al.  Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  M. Greene,et al.  The Concise Handbook of Family Cancer Syndromes , 1998 .

[74]  Adopted on March.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[75]  Sean V Tavtigian,et al.  Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  W F Bodmer,et al.  Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. , 2001, American journal of human genetics.

[77]  D. Berry,et al.  Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. , 1997, Journal of the National Cancer Institute.

[78]  C Eng,et al.  Low frequency of germline mutations in the RET proto‐oncogene in patients with apparently sporadic medullary thyroid carcinoma , 1995, Clinical endocrinology.

[79]  Kentaro Takahashi,et al.  Von Hippel-Lindau Disease , 2024 .

[80]  K. Kinzler,et al.  The multistep nature of cancer. , 1993, Trends in genetics : TIG.

[81]  M. Greene,et al.  The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. , 1998, Journal of the National Cancer Institute.

[82]  E. Ostrander,et al.  Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations inBRCA1 , 2001, Journal of medical genetics.

[83]  E. Thomson,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. , 1997, JAMA.

[84]  J. Carpten,et al.  Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk , 2002, Nature Genetics.

[85]  K. Klinger,et al.  Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 , 2002, Nature Genetics.

[86]  Penny Hopwood.  Psychological issues in cancer genetics: current research and future priorities. , 1997, Patient education and counseling.

[87]  R. Croyle,et al.  Psychologic aspects of cancer genetic testing , 1997, Cancer.

[88]  M. Daly,et al.  Attitudes about genetic testing for breast-ovarian cancer susceptibility. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89]  K. Kinzler,et al.  The Genetic Basis of Human Cancer , 1997 .

[90]  Victor E. Velculescu,et al.  Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis , 2001, Nature Genetics.

[91]  T. Sellers,et al.  Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. , 2001, Journal of the National Cancer Institute.

[92]  K. Sweet,et al.  Identification and referral of families at high risk for cancer susceptibility. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[93]  J. Struewing,et al.  Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[94]  M. Skolnick,et al.  Genetic susceptibility to breast and ovarian cancer. , 1997, Pathologie-biologie.

[95]  T. Beaty,et al.  Mendelian inheritance of familial prostate cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[96]  N. Boyd,et al.  Accuracy of family cancer history in breast cancer patients , 1994, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[97]  L. Aaltonen,et al.  Mutations in the SMAD4/DPC4 gene in juvenile polyposis. , 1998, Science.

[98]  M. Wiench,et al.  Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[99]  J. Schipper,et al.  Germ-line mutations in nonsyndromic pheochromocytoma. , 2002, The New England journal of medicine.

[100]  N. Risch,et al.  The calculation of breast cancer risk for women with a first degree family history of ovarian cancer , 1993, Breast Cancer Research and Treatment.

[101]  M. Fiddler,et al.  Practice-based competencies for accreditation of and training in graduate programs in genetic counseling , 1996, Journal of Genetic Counseling.

[102]  K. Offit.  Clinical Cancer Genetics: Risk Counseling and Management , 1998 .

[103]  H. Green.  Survey of Cancer , 1955, Nature.

[104]  B. Rimer,et al.  Effects of individualized breast cancer risk counseling: a randomized trial. , 1995, Journal of the National Cancer Institute.

[105]  N Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.